Posted today in FDA Alerts

Ocaliva (obeticholic acid): Drug Safety Communication - Increased Risk of Serious Liver Injury

[Posted 09/21/2017] ISSUE: FDA is warning that the liver disease medicine Ocaliva (obeticholic acid) is being incorrectly dosed in some patients with moderate to severe decreases in liver function, resulting in an increased risk of serious liver injury and death. These patients are receiving excessive dosing, particularly a higher frequency of dosing...

Posted today in Medical

For Men, Fitness Can Often Last a Lifetime

Active middle-aged men are likely to stay active into old age, a new study finds. The research included nearly 3,500 British men, aged 40 to 59 at the start of the study. The researchers followed the men's health for 20 years. Those who were physically active in mid-life were nearly three times more likely to be active at the end of the study period. Men...

Posted today in Medical

Health Tip: Stair Safety For Older People

-- Some elderly people are at heightened risk for falling, especially at home. Six of 10 falls occur within the home -- often due to lax stair safety, the National Institute on Aging says. The agency offers these safety suggestions: Install tightly-fastened handrails on both sides of the stairs. Always hold the handrails while going up and down...

Posted 3 days ago in New Drug Approvals

FDA Approves Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women

(BUSINESS WIRE) September 18, 2017 --Symbiomix Therapeutics today announced the U.S. Food and Drug Administration (FDA) has approved Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women. Solosec is a potent, next-generation, 5-nitroimidazole antibiotic with enhanced pharmacokinetic properties that enable...

Posted 3 days ago in New Drug Approvals

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with...

Posted 3 days ago in Clinical Trials

Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics, today announced positive topline results...

Posted today in Medical

Health Tip: Prevent Carbon Monoxide Poisoning

-- Carbon monoxide (CO) is routinely called a "silent killer," since the toxic gas is odorless and tasteless. More than 400 people die each year in the United States from accidental carbon monoxide poisoning, and more than 50,000 people visit the emergency room due to CO exposure, the CDC says. The agency suggests how to reduce your chances of CO...

Posted today in Medical

Inflammatory Bowel Disease May Raise Cancer Risk in Kids

Children with inflammatory bowel disease (IBD) face an increased risk of cancer, a new study claims. The risk persists into adulthood, and is especially elevated for gastrointestinal cancers, the researchers added. The "extent and duration of chronic inflammation might be the main driving mechanisms underlying the increased risk of cancer," the researchers...

Posted today in Medical

Could Pests, Dust Lower Kids' Odds for Asthma?

Early exposure to pest and pet allergens -- cockroaches and mice droppings included -- may actually guard children against asthma, a new study of inner-city kids suggests. "This confirms a similar finding last year that June Cleaver was, in fact, wrong," said Dr. Kelvin MacDonald, a pediatric lung specialist at Doernbecher Children's Hospital in Oregon...

Posted today in Medical

Health Highlights: Sept. 21, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: More Fetal Deaths, Fewer Pregnancies When Flint Had High Lead Levels in Drinking Water: Study There was an increase in fetal deaths and a decrease in pregnancies when Flint, Michigan had high levels of lead in its drinking water, a new study says. The...

Recently added consumer and prescribing information: Aliqopa, benznidazole, Kymriah, Duzallo, Mavyret, Idhifa, Vosevi, Nerlynx, Tremfya, Bevyxxa

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]